Improving human health through precision microbiome testing

Co-Biome’s™ parent brand Microba™ was founded in 2016 at the University of Queensland by Professor Gene Tyson and Professor Philip Hugenholtz, who are globally recognised leaders in the field of Metagenomic Sequencing of the microbiome.

Professor Tyson and Professor Hugenholtz are responsible for pioneering major advancements in metagenomic sequencing and setting new standards for the classification of microorganisms. Together they founded Microba with the goal of unlocking human health through the microbiome by advancing testing techniques, uncovering deeper insights and advancing microbiome-related interventions and therapeutics to improve patient health outcomes through research-quality microbiome analysis.

Microba’s first gut microbiome kit and report, Insight™, was released giving Australian healthcare professionals and consumers the opportunity to accurately measure their gut microbiome and receive personalised, science-based insights and practical recommendations.

Co-Biome’s™ parent brand Microba™ continued to gain international interest after publishing numerous groundbreaking scientific articles. A number of these articles were published in the influential academic journal Nature including A complete domain-to-species taxonomy for Bacteria and Archaea and Critical evaluation of faecal microbiome preservation using metagenomic analysis. The Microba™ team continued to grow to acquire a number of new global microbiome experts to continue advancing human health through the microbiome.

The Co-Biome™ Clinical Science team was created including industry leading Scientists, Researchers, Naturopaths and Nutritionists. The team was tasked with reviewing the gut microbiome and gastrointestinal health literature to critically evaluate diet, lifestyle and supplement research and clinical insights. Using the NHMRC guidelines for developing recommendations, the team spent over 7000 hours reviewing over 1200 papers, answering over 300 research questions and developing over 80 clinical and research insights that you now find in the Co-Biome MetaXplore reports.

The Microba lab, that Co-Biome share, at the Translational Research Institute, Brisbane was NATA accredited for Human Pathology (ISO 15189). Achieving NATA accreditation means the Microba lab has been successful in consistently meeting international laboratory standards. This ensures that healthcare professionals and their patients can trust they will receive reliable and quality results, every time.

Co-Biome™ launches in Australia and releases the MetaXplore range of diagnostic gastrointestinal and metagenomic-driven gut microbiome profiles.